144 related articles for article (PubMed ID: 1547414)
1. Aggressiveness of breast cancers found with and without screening.
Klemi PJ; Joensuu H; Toikkanen S; Tuominen J; Räsänen O; Tyrkkö J; Parvinen I
BMJ; 1992 Feb; 304(6825):467-9. PubMed ID: 1547414
[TBL] [Abstract][Full Text] [Related]
2. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
3. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
[TBL] [Abstract][Full Text] [Related]
4. Breast cancers found by screening: earlier detection, lower malignant potential or both?
Ernst MF; Roukema JA; Coebergh JW; Repelaer van Driel OJ; van Beek MW; van der Sangen MJ; Voogd AC
Breast Cancer Res Treat; 2002 Nov; 76(1):19-25. PubMed ID: 12408372
[TBL] [Abstract][Full Text] [Related]
5. Mammographic screening for breast cancer. What cancers do we find?
Nordén T; Thurfjell E; Hasselgren M; Lindgren A; Norgren A; Bergström R; Holmberg L
Eur J Cancer; 1997 Apr; 33(4):624-8. PubMed ID: 9274445
[TBL] [Abstract][Full Text] [Related]
6. Detecting which invasive cancers at mammographic screening saves lives?
Evans AJ; Pinder SE; Burrell HC; Ellis IO; Wilson AR
J Med Screen; 2001; 8(2):86-90. PubMed ID: 11480449
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening interval and the frequency of interval cancers in a population-based screening.
Klemi PJ; Toikkanen S; Räsänen O; Parvinen I; Joensuu H
Br J Cancer; 1997; 75(5):762-6. PubMed ID: 9043038
[TBL] [Abstract][Full Text] [Related]
8. Tumour-related factors and prognosis in breast cancer detected by screening.
Olsson A; Borgquist S; Butt S; Zackrisson S; Landberg G; Manjer J
Br J Surg; 2012 Jan; 99(1):78-87. PubMed ID: 22068957
[TBL] [Abstract][Full Text] [Related]
9. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
[TBL] [Abstract][Full Text] [Related]
10. Tumor characteristics in screen-detected and symptomatic breast cancers.
Pálka I; Kelemen G; Ormándi K; Lázár G; Nyári T; Thurzó L; Kahán Z
Pathol Oncol Res; 2008 Jun; 14(2):161-7. PubMed ID: 18347932
[TBL] [Abstract][Full Text] [Related]
11. Assessing the effectiveness of a mammography screening service.
Clayforth C; Fritschi L; McEvoy S; Byrne MJ; Wylie E; Threlfall T; Sterrett G; Harvey JM; Jamrozik K
ANZ J Surg; 2005 Aug; 75(8):631-6. PubMed ID: 16076321
[TBL] [Abstract][Full Text] [Related]
12. Primary tumour characteristics and axillary lymph node status in breast cancer.
Yiangou C; Shousha S; Sinnett HD
Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
[TBL] [Abstract][Full Text] [Related]
13. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
14. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
[TBL] [Abstract][Full Text] [Related]
15. Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening.
Joensuu H; Toikkanen S; Klemi PJ
Br J Cancer; 1991 Sep; 64(3):588-92. PubMed ID: 1911203
[TBL] [Abstract][Full Text] [Related]
16. Detection method, tumour size and node metastases in breast cancers diagnosed during a trial of breast cancer screening.
Tabar L; Duffy SW; Krusemo UB
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):959-62. PubMed ID: 3311769
[TBL] [Abstract][Full Text] [Related]
17. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
18. Cytometric characterization and clinical course of breast cancer diagnosed in a population-based screening program.
Hatschek T; Fagerberg G; Stål O; Sullivan S; Carstensen J; Gröntoft O; Nordenskjöld B
Cancer; 1989 Sep; 64(5):1074-81. PubMed ID: 2758384
[TBL] [Abstract][Full Text] [Related]
19. Season of tumour detection influences factors predicting survival of patients with breast cancer.
Mason BH; Holdaway IM; Stewart AW; Neave LM; Kay RG
Breast Cancer Res Treat; 1990 Jan; 15(1):27-37. PubMed ID: 2328328
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 2552 consecutive patients.
Majid S; Rydén L; Manjer J
World J Surg Oncol; 2018 Mar; 16(1):54. PubMed ID: 29530065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
